Literature DB >> 19846740

Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

S Alsamarai1, J M Adams, M K Murphy, M D Post, D L Hayden, J E Hall, C K Welt.   

Abstract

CONCEPT: Ovaries meeting criteria for polycystic ovary morphology during peak reproductive years may no longer meet the criteria with age.
OBJECTIVE: Ovarian volume and follicle number decrease with age in women with polycystic ovary syndrome (PCOS), permitting age-dependent criteria for PCOM. DESIGN AND
SETTING: We conducted longitudinal (7-15 year interval) and cross-sectional studies to examine polycystic ovarian morphology over time at an outpatient clinic and pathology laboratory in a tertiary care hospital. PATIENTS: Subjects included those with PCOS defined by the National Institutes of Health criteria (n = 11 and 483 for longitudinal and cross-sectional, respectively) and control women with regular menstrual cycles and no hyperandrogenism (n = 15 and 367), age 18-64 yr.
INTERVENTIONS: Subjects underwent an ovarian ultrasound by a single observer. MAIN OUTCOME MEASURES: Ovarian volume and follicle number were measured and ultrasound findings confirmed by a pathologist in a subset (n = 9).
RESULTS: Ovarian volume (15.2 +/- 7.4 vs. 7.1 +/- 3.7 ml; P < 0.01) and follicle number (12.8 +/- 3.2 vs. 8.1 +/- 3.9; P < 0.05) decreased longitudinally in PCOS and control women (volume 11.6 +/- 4.4 vs. 5.4 +/- 2.2 ml and follicle number 8.3 +/- 1.9 vs. 6.3 +/- 1.8; both P < 0.005). Using cross-sectional data, log ovarian volume and follicle number decreased in both groups, but the decrease in log ovarian volume was less pronounced in women with PCOS than in controls (P < 0.01). A combination of age, log ovarian volume, follicle number, and testosterone distinguished PCOS subjects from controls with a receiver operator characteristic curve area of 0.90.
CONCLUSIONS: Ovarian volume and follicle number decrease with age in women with PCOS and controls necessitating age-based criteria to define polycystic ovarian morphology. It is possible to use these criteria to distinguish PCOS in women over age 40 yr.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846740      PMCID: PMC2795657          DOI: 10.1210/jc.2009-0839

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

1.  Age-related changes in ovarian volume, antral follicle counts and basal FSH in women with normal reproductive health.

Authors:  Ahmet Erdem; Mehmet Erdem; Kutay Biberoglu; Ozkan Hayit; Murat Arslan; Rifat Gursoy
Journal:  J Reprod Med       Date:  2002-10       Impact factor: 0.142

2.  Ovarian volume related to age.

Authors:  E J Pavlik; P D DePriest; H H Gallion; F R Ueland; M B Reedy; R J Kryscio; J R van Nagell
Journal:  Gynecol Oncol       Date:  2000-06       Impact factor: 5.482

3.  Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography.

Authors:  Frank J Broekmans; Malcolm Faddy; Egbert R te Velde
Journal:  Hum Reprod       Date:  2005-04       Impact factor: 6.918

4.  Polycystic ovaries in pre and post-menopausal women.

Authors:  M A Birdsall; C M Farquhar
Journal:  Clin Endocrinol (Oxf)       Date:  1996-03       Impact factor: 3.478

5.  Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion.

Authors:  S J Richardson; V Senikas; J F Nelson
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

6.  Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility.

Authors:  G J Scheffer; F J Broekmans; M Dorland; J D Habbema; C W Looman; E R te Velde
Journal:  Fertil Steril       Date:  1999-11       Impact factor: 7.329

7.  The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.

Authors:  R Pasquali; A Gambineri; B Anconetani; V Vicennati; D Colitta; E Caramelli; F Casimirri; A M Morselli-Labate
Journal:  Clin Endocrinol (Oxf)       Date:  1999-04       Impact factor: 3.478

8.  Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.

Authors:  J Adams; S Franks; D W Polson; H D Mason; N Abdulwahid; M Tucker; D V Morris; J Price; H S Jacobs
Journal:  Lancet       Date:  1985 Dec 21-28       Impact factor: 79.321

9.  Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.

Authors:  Johanna Puurunen; Terhi Piltonen; Päivi Jaakkola; Aimo Ruokonen; Laure Morin-Papunen; Juha S Tapanainen
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

10.  Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones.

Authors:  E Dahlgren; S Johansson; G Lindstedt; F Knutsson; A Odén; P O Janson; L A Mattson; N Crona; P A Lundberg
Journal:  Fertil Steril       Date:  1992-03       Impact factor: 7.329

View more
  26 in total

Review 1.  The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.

Authors:  Robert L Rosenfield
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-08-27       Impact factor: 1.814

2.  Sustained fertility from 22 to 41 years of age in women with polycystic ovarian syndrome.

Authors:  Jan R Mellembakken; Sarah L Berga; Mirjam Kilen; Tom G Tanbo; Thomas Abyholm; Peter Fedorcsák
Journal:  Hum Reprod       Date:  2011-06-30       Impact factor: 6.918

3.  Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.

Authors:  R Saxena; A C Bjonnes; N A Georgopoulos; V Koika; D Panidis; C K Welt
Journal:  Hum Reprod       Date:  2015-05-20       Impact factor: 6.918

4.  Polycystic ovary morphology: age-based ultrasound criteria.

Authors:  Hyun-Jun Kim; Judith M Adams; Jens A Gudmundsson; Gudmundur Arason; Cindy T Pau; Corrine K Welt
Journal:  Fertil Steril       Date:  2017-08-12       Impact factor: 7.329

Review 5.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

Review 6.  Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome.

Authors:  Márcia Marly Winck Yamamoto; Sebastião Freitas de Medeiros
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

7.  Gonadal dysfunction in morbidly obese adolescent girls.

Authors:  Vivian Chin; Marisa Censani; Shulamit Lerner; Rushika Conroy; Sharon Oberfield; Donald McMahon; Jeffrey Zitsman; Ilene Fennoy
Journal:  Fertil Steril       Date:  2014-02-26       Impact factor: 7.329

Review 8.  The role of TGF-β in polycystic ovary syndrome.

Authors:  Nazia Raja-Khan; Margrit Urbanek; Raymond J Rodgers; Richard S Legro
Journal:  Reprod Sci       Date:  2013-04-12       Impact factor: 3.060

9.  Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.

Authors:  Corrine K Welt; Enrico Carmina
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

10.  The Effect of Ageing on Clinical, Hormonal and Sonographic Features Associated with PCOS-A Long-Term Follow-Up Study.

Authors:  Małgorzata Jacewicz-Święcka; Sławomir Wołczyński; Irina Kowalska
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.